ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
0,00%
Bitcoin
63.675,32
0,42%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX

Novavax (NVAX)

Novavax Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DatumZeitQuelleÜberschriftSymbolFirma
15/04/202412h00GlobeNewswire Inc.Shah Capital nominates two highly qualified independent director candidates for NovavaxNASDAQ:NVAXNovavax Inc
01/04/202414h00PR Newswire (US)Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024NASDAQ:NVAXNovavax Inc
06/03/202401h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
29/02/202422h02PR Newswire (US)Novavax to Participate in TD Cowen's 44th Annual Health Care ConferenceNASDAQ:NVAXNovavax Inc
28/02/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
28/02/202414h00PR Newswire (US)Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
28/02/202413h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVAXNovavax Inc
23/02/202414h03IH Market NewsGoldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and MoreNASDAQ:NVAXNovavax Inc
22/02/202412h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
22/02/202412h00PR Newswire (US)Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementNASDAQ:NVAXNovavax Inc
20/02/202415h25PR Newswire (US)Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024NASDAQ:NVAXNovavax Inc
31/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
25/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
08/01/202415h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
03/01/202415h25PR Newswire (US)Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NVAXNovavax Inc
18/12/202323h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
18/12/202323h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
18/12/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
18/12/202314h00PR Newswire (US)Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in TaiwanNASDAQ:NVAXNovavax Inc
13/12/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
13/12/202323h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
13/12/202314h31Dow Jones NewsModerna Shares, Other Covid Vaccine Makers Hit by Warning From PfizerNASDAQ:NVAXNovavax Inc
13/12/202314h00PR Newswire (Canada)Canadians Can Help Protect Loved Ones as We Head into the Holiday SeasonNASDAQ:NVAXNovavax Inc
05/12/202322h01PR Newswire (US)Novavax's Updated COVID-19 Vaccine Now Authorized in CanadaNASDAQ:NVAXNovavax Inc
05/12/202322h01PR Newswire (Canada)Novavax's Updated COVID-19 Vaccine Now Authorized in CanadaNASDAQ:NVAXNovavax Inc
05/12/202314h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
28/11/202319h13IH Market NewsWall Street Radar: Amazon, Blackrock, General Motors, Eli Lilly, Novavax..NASDAQ:NVAXNovavax Inc
28/11/202312h00PR Newswire (US)Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health OrganizationNASDAQ:NVAXNovavax Inc
17/11/202322h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
17/11/202313h15PR Newswire (US)Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic PrioritiesNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Kürzlich von Ihnen besucht

USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
TG
CBK
Commerzbank
DBI
TDXP
Tec DAX
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
GOOGL
Alphabet
TG
432
Arbor Metals
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
TG
LHA
Deutsche Lufthansa
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
TG
DTE
Deutsche Telekom
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten